QuellTX Logo

Restoring the Balance With Regulatory T cell Therapies

Harnessing the suppressive capacity of Tregs to address immune dysfunction utilising modular engineered Tregs. Addressing a range of autoimmune and inflammatory diseases as well as preventing rejection in organ transplantation

Welcome to Quell

Quell Therapeutics is a London, UK based, private biopharmaceutical company. Our vision is to be the leading engineered cell therapy company, bringing transformational and valued therapies addressing a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation.

Latest News

29/11/21

Quell Therapeutics Raises $156 million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform

- Series B co-led by Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company LLC, alongside founding investor Syncona and includes a broad syndicate of international life science focused investors - Proceeds to be used…...

Read More
22/11/21

Quell Therapeutics Announces Participation in Upcoming Investor Conferences

London, UK and Boston, MA – November 22, 2021 – Quell Therapeutics Ltd (“Quell”), the world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, today announced that management will…...

Read More
27/10/21

Quell Therapeutics Granted CTA Approval to Begin First Clinical Trial with a Multi-modular Engineered Treg Cell Therapy

First clinical trial will investigate QEL-001 as a novel treatment to prevent organ rejection in liver transplant patients and eliminate the need for lifelong systemic immunosuppression London, UK and Boston, MA, USA – October 27, 2021 – Quell Therapeutics Ltd (“Quell”),…...

Read More

Quell Introduction

Find out more about our vision to bring truly innovative, life changing Treg therapies for our patients as we build a major global biopharmaceutical company as well as what it’s like to work for Quell.

Quell Introduction

Find out more about our vision to bring truly innovative, life changing Treg therapies for our patients as we build a major global biopharmaceutical company as well as what it’s like to work for Quell.